Pulmonary
  • Asthma
  • COPD
  • Pulmonary
amPulmonary Insights
amPulmonary Insights
amPulmonary enewsletter is the hub of news and cutting-edge information for pulmonary clinicians, researchers, and medical professionals interested in the latest developments.
Topics
  • Asthma
  • COPD
  • Pulmonary
Resources
  • Subscribe
  • About Us
  • Contact Us
  • Sign In
  • Sign In
  • Asthma
  • COPD
  • Pulmonary
  • Subscribe

Site Map

  1. 2023
  2. March
  3. 24
New American Lung Association Research Institute to accelerate high impact, lifesaving lung health science
Dupilumab demonstrates potential to become first biologic to treat COPD by showing reduction in exacerbations in trial
Global COPD market size to grow $35.9 billion by 2030
Data show single tablet combination therapy of macitentan and tadalafil improves pulmonary hemodynamics vs monotherapy in patients with PAH
Page 1 of 1
Pulmonary
Newsletter for Professionals
amPulmonary enewsletter is the hub of news and cutting-edge information for pulmonary clinicians, researchers, and medical professionals interested in the latest developments.
Topics
  • Asthma
  • COPD
  • Pulmonary
  1. Privacy Policy
  2. About Us
  3. Terms & Conditions
  4. Contact Us
  5. Site Map
© 2025 Ascend Integrated Media. All rights reserved.